| Date Filed | Type | Description |
| 03/02/2023 |
4
| Salvadori Daniel Gesua Sive (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 9,002 shares
@ $99.77, valued at
$898.1k
Sold 1,085 shares
@ $100.7, valued at
$109.3k
|
|
| 02/22/2023 |
4
| Salvadori Daniel Gesua Sive (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 17,700 shares
@ $0
Granted 69,803 options to buy
@ $106.24, valued at
$7.4M
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Salvadori Daniel Gesua Sive (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 23,919 shares
@ $0
Granted 111,474 options to buy
@ $117.58, valued at
$13.1M
|
|
| 12/28/2021 |
4
| Salvadori Daniel Gesua Sive (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 58,501 shares
@ $140, valued at
$8.2M
Exercised 23,771 options to buy
@ $38.4, valued at
$912.8k
Exercised 31,229 options to buy
@ $44.4, valued at
$1.4M
|
|
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2020 |
4
| Salvadori Daniel Gesua Sive (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 42,479 shares
@ $111.86, valued at
$4.8M
Exercised 42,479 options to buy
@ $47, valued at
$2M
|
|
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2019 |
4
| Salvadori Daniel Gesua Sive (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 1,060 shares
@ $87.49, valued at
$92.7k
|
|
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2019 |
4
| Salvadori Daniel Gesua Sive (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 7,269 shares
@ $82, valued at
$596.1k
Sold 3,331 shares
@ $82, valued at
$273.1k
|
|
| 03/04/2019 |
4
| Salvadori Daniel Gesua Sive (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 11,097 shares
@ $77.23, valued at
$857k
Sold 1,664 shares
@ $78, valued at
$129.8k
|
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2018 |
4
| Salvadori Daniel Gesua Sive (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 1,060 shares
@ $63.32, valued at
$67.1k
|
|
| 05/21/2018 |
4
| Salvadori Daniel Gesua Sive (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 2,000 shares
@ $61.046, valued at
$122.1k
Sold 1,000 shares
@ $61.5, valued at
$61.5k
|
|
| 03/02/2018 |
4
| Salvadori Daniel Gesua Sive (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 8,578 shares
@ $60.55, valued at
$519.4k
Sold 905 shares
@ $58.971, valued at
$53.4k
|
|
| 02/21/2018 |
4
| Salvadori Daniel Gesua Sive (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 33,266 shares
@ $0
Granted 182,935 options to buy
@ $59.94, valued at
$11M
|
|
| 12/14/2017 |
4
| Salvadori Daniel Gesua Sive (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 9,839 shares
@ $54.901, valued at
$540.2k
Sold 1,483 shares
@ $54.91, valued at
$81.4k
Sold 200 shares
@ $54.911, valued at
$11k
Sold 200 shares
@ $54.915, valued at
$11k
Sold 1,900 shares
@ $54.92, valued at
$104.3k
Sold 100 shares
@ $54.9214, valued at
$5.5k
Sold 6,897 shares
@ $54.93, valued at
$378.9k
Sold 7,700 shares
@ $54.935, valued at
$423k
Exercised 28,319 options to buy
@ $47, valued at
$1.3M
|
|
| 11/16/2017 |
4
| Salvadori Daniel Gesua Sive (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 71,157 shares
@ $55, valued at
$3.9M
Exercised 71,157 options to buy
@ $38.4, valued at
$2.7M
|
|
| 10/25/2017 |
4
| Salvadori Daniel Gesua Sive (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 96,603 shares
@ $56.21, valued at
$5.4M
Exercised 34,142 options to buy
@ $42.08, valued at
$1.4M
Exercised 28,319 options to buy
@ $47, valued at
$1.3M
|
|
| 09/28/2017 |
4
| Salvadori Daniel Gesua Sive (Senior Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 62,460 shares
@ $52.95, valued at
$3.3M
Paid exercise price by delivering 5,487 shares
@ $52.61, valued at
$288.7k
Exercised 34,141 options to buy
@ $42.08, valued at
$1.4M
Exercised 28,319 options to buy
@ $47, valued at
$1.3M
|
|
| 07/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/28/2016 |
4
| Salvadori Daniel Gesua Sive (Senior Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 2,001 shares
@ $42.19, valued at
$84.4k
Sold 815 shares
@ $41.711, valued at
$34k
|
|
| 03/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |